๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

G-Csf

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 12 trials in our China, Ireland, UK, USA and India registers that name G-Csf as an intervention. Synced 24 Sep 2026
12Trials tracked
10Recruiting now
10Lead sponsors
5Country registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards

G-Csf is named as a drug or biological intervention in 12 clinical trials in our China, Ireland, UK, USA and India trial registers, 10 of which are recruiting. Lead sponsors include First Affiliated Hospital of Zhejiang University (2), The Affiliated People's Hospital of Ningbo University (2) and St. Anna Kinderkrebsforschung (1). Registered phases: Phase 3, Phase 2, Not applicable and Phase 2/3. Conditions studied include Multiple Myeloma; Hematopoietic Stem Cell Mobilization; Neuroblastoma.

01

Clinical trials of G-Csf

12 trials
NCT IDStudyPhaseStatusLead sponsorRegister
NCT01704716 High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) (ClinicalTrials.gov ↗)
Neuroblastoma
Phase 3 Recruiting St. Anna Kinderkrebsforschung Ireland
NCT06514508 Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients (ClinicalTrials.gov ↗)
Multiple Myeloma
Phase 3 Recruiting Guangzhou Gloria Biosciences Co., Ltd. China
NCT06520163 Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma (ClinicalTrials.gov ↗)
Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization
Phase 3 Recruiting The Affiliated People's Hospital of Ningbo University China
NCT06520176 Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients (ClinicalTrials.gov ↗)
Multiple Myeloma, Hematopoietic Stem Cell Mobilization
Phase 3 Recruiting The Affiliated People's Hospital of Ningbo University China
NCT07692841 Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors (ClinicalTrials.gov ↗)
Healthy Hematopoietic Stem Cell Donor, Healthy Allogeneic Hematopoietic Stem Cell Donor
Phase 3 Recruiting First Affiliated Hospital of Zhejiang University China
NCT05139017 A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003) (ClinicalTrials.gov ↗)
DLBCL, Diffuse Large B-Cell Lymphoma
Phase 2/3 Recruiting Merck Sharp & Dohme LLC UK, USA, China
NCT06890039 A-TANGO Phase 2 Study (ClinicalTrials.gov ↗)
Acute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic
Phase 2 Recruiting Yaqrit Ltd UK
NCT07362810 G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation (ClinicalTrials.gov ↗)
Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB), Hematopoetic Stem Cell Transplantation, Hemato-oncologic Patients
Phase 2 Recruiting Fudan University China
NCT07002827 Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.
Decompensated Liver Cirrhosis
Not applicable Recruiting Institute of Liver and Biliary Sciences, India India
NCT07423728 CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors (ClinicalTrials.gov ↗)
Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization
Not applicable Recruiting First Affiliated Hospital of Zhejiang University China
NCT02375204 Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors (ClinicalTrials.gov ↗)
Germ Cell Tumor, Teratoma, Choriocarcinoma
Phase 3 Active, closed Alliance for Clinical Trials in Oncology Ireland
NCT03246529 A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM) (ClinicalTrials.gov ↗)
Multiple Myeloma
Phase 3 Active, closed BioLineRx, Ltd. USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied

20 conditions
Condition (as registered)Trials
Multiple Myeloma3
Hematopoietic Stem Cell Mobilization2
Neuroblastoma1
Germ Cell Tumor1
Teratoma1
Choriocarcinoma1
Germinoma1
DLBCL1
Diffuse Large B-Cell Lymphoma1
Acute-On-Chronic Liver Failure1
Alcoholic Hepatitis1
Liver Cirrhosis, Alcoholic1
Decompensated Liver Cirrhosis1
Healthy Hematopoietic Stem Cell Donor1
Healthy Allogeneic Hematopoietic Stem Cell Donor1
Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)1
Hematopoetic Stem Cell Transplantation1
Hemato-oncologic Patients1
Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization1
Non-Hodgkin's Lymphoma1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
First Affiliated Hospital of Zhejiang University2
The Affiliated People's Hospital of Ningbo University2
St. Anna Kinderkrebsforschung1
Alliance for Clinical Trials in Oncology1
Merck Sharp & Dohme LLC1
Yaqrit Ltd1
BioLineRx, Ltd.1
Institute of Liver and Biliary Sciences, India1
Fudan University1
Guangzhou Gloria Biosciences Co., Ltd.1
04

Trials by country register

A trial with sites in more than one country appears in each of those registers.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how G-Csf works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists G-Csf (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.